Filing Details

Accession Number:
0001213900-24-111723
Form Type:
13G Filing
Publication Date:
2024-12-22 19:00:00
Filed By:
Longling Capital Ltd
Company:
Nano Labs Ltd
Filing Date:
2024-12-23
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Longling Capital Ltd 0 1,547,988 9.6%
Wensheng Cai 0 1,547,988 9.6%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Row (11) is based on 16,108,955 outstanding ordinary shares as a single class, being the sum of 13,250,046 Class A ordinary shares and 2,858,909 Class B ordinary shares outstanding as of December 11, 2024 as provided by Nano Labs Ltd, assuming conversion of all Class B ordinary shares into Class A ordinary shares.


SCHEDULE 13G



Comment for Type of Reporting Person:  Rows (5), (7) and (9) represent 1,547,988 Class A ordinary shares held of record by Longling Capital Ltd. Wensheng Cai is the sole shareholder of Longling Capital Ltd. Row (11) is based on 16,108,955 outstanding ordinary shares as a single class, being the sum of 13,250,046 Class A ordinary shares and 2,858,909 Class B ordinary shares outstanding as of December 11, 2024 as provided by Nano Labs Ltd, assuming conversion of all Class B ordinary shares into Class A ordinary shares.


SCHEDULE 13G


 
Longling Capital Ltd
 
Signature:/s/ Wensheng Cai
Name/Title:Wensheng Cai/Director
Date:12/23/2024
 
Wensheng Cai
 
Signature:/s/ Wensheng Cai
Name/Title:Wensheng Cai
Date:12/23/2024
Exhibit Information

A Joint Filing Agreement